A new lawsuit has been filed against Monsanto Company. The plaintiff, Jeffrey J., alleges that he developed cancer from Roundup, the popular herbicide created by Monsanto. Jeffrey J. alleges he was diagnosed with non-Hodgkin’s lymphoma cancer due to his exposure to Roundup.
The main active ingredient in Roundup is glyphosate, and Monsanto Company is the world’s leading manufacturer of this chemical. The Monsanto company is headquartered in St. Louis, Missouri, but distributes its herbicidal products globally, domestically, and specifically in the State of Pennsylvania, where the plaintiff, Jeffrey J., resides.
According to this cancer from Roundup lawsuit, Monsanto Company has been in the possession of a body of evidence pointing to glyphosate’s genetic human toxicity for several decades. Despite this knowledge, the company has maintained through its promotion of the herbicide that it is ‘safer than table salt’ and that the product is for the most part non-toxic to animals—mammals, birds, fish that come into contact with it.
The International Agency for Research on Cancer (IARC), a division of the World Health Organization (WHO), published results of a review of this evidence in the spring of 2015. The conclusion was that cancer from exposure Roundup was possible because glyphosate was a probable human carcinogen.
Specifically, IARC noted that there was significant risk of developing a host of different blood-related cancers in individuals that routinely came in contact with the herbicidal ingredient during the course of their professional lives such as farmers, farm hands, and landscapers. Additionally, IARC was able to conclude that glyphosate likely produced damage to human chromosomes.
In 1985, a full thirty years prior to this conclusion by IARC, the U.S. Environmental Protection Agency (EPA) made an initial judgment referencing glyphosate also as probably carcinogenic. According to the cancer from Roundup lawsuit, Monsanto Company put significant pressure on the federal oversight organization to change the active ingredient to a different classification group. According to the cancer from Roundup lawsuit, there was also evidence uncovered that the Monsanto Company engaged in scientific fraud by tampering with the conclusions drawn into report format from raw data in 1983 and 1990.
The Plaintiff’s Story
The plaintiff, Jeffrey J., was a professional landscaper who used Roundup products from 1984 to 2016 in his work and on his personal property according to the developer’s instructions. In September of 2017, he was diagnosed with non-Hodgkin’s lymphoma cancer allegedly from Roundup use. The plaintiff is bringing the following counts against the Monsanto Company:
Count One—Negligence; Count Two—Strict Products Liability, Design Defects; Count Three—Strict Products Liability, Failure to Warn; Count Four—Breach of Express Warranty; Count Five, and Breach of Implied Warranties.
Jeffrey J. is asking for a trial by jury with a compensatory award reflecting his pain, suffering, emotional distress, health care costs, and loss of earning power. He asks for punitive damages to be assessed against the Monsanto company for the wanton abuse of power against the consuming public. Finally, he hopes for a return of all court and attorney fees.
The Cancer from Roundup Lawsuit is Case No. 2:17-cv-05576-MMB in U.S. District Court, Eastern District of Pennsylvania.
If you or a loved one developed cancer after using Roundup as a farm worker or home gardener, you may have a legal claim. Legal migrant farm workers may also seek help. Learn more by filling out the form on this page for a FREE case evaluation.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2025 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Roundup Cancer Class Action Lawsuit Investigation
For the most up-to-date information on this case, click here.